ARCHIVES

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

This article is from The Cancer Letter archive.

Vol. 21 No. 08 | February 24, 1995

Download PDF Visit The Full Archive

Related Articles

Iressa Just As Effective As Chemotherapy For Second-Line Therapy, Study Finds

November 28, 2008

Lippman Named UCSD Cancer Center Director

May 4, 2012

Phase 1 AIDS Vaccine Trial Will Involve 81 Persons At NIH

August 28, 1987

NCI Disappointed Over Response To Survey Leads; CRAG Proposals Inadequate, More Will Be Sought

August 6, 1976

Of Smokers Screened With CT In Study, 7% Have Lung Cancer

December 31, 2004

Reaction To PSA Guideline Muffled Compared to 2009 Mammography Guideline

October 14, 2011